Summary
A large-scale, prospective study of tardive dyskinesia (TD) was performed in 11 psychiatric facilities in Japan. A total of 1595 psychiatric patients were enrolled in this study in 1987. The progress of these patients, with the exception of 490 dropouts, has now been followed up to 1988. The prevalence of TD at study entry was 7.6%, the annual incidence rate was 3.7% and the annual remission rate was 28.7%. Newly developed TD patients tended to be older, to have undergone more psychosurgery, and to have had lower neuroleptic doses than the patients who had not developed TD, whereas no specific variable could be detected as a factor associated with remission of TD. The results suggest that the incidence of TD is lower in Japan than that in Europe and North America.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barnes TRE (1987) The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia. Psychiatr Dev 5:301–319
Barnes TRE, Kidger T, Gore SM (1983) Tardive dyskinesia: a 3-year follow-up study. Psychol Med 13:71–81
Binder RL, Levy R (1981) Extrapyramidal reactions in Asians. Am J Psychiatry 138:1243–1244
Chouinard G, Annable L, Mercier P, Ross-Chouinard A (1986) A five-year follow-up study of tardive dyskinesia. Psychopharmacol Bull 22:259–263
Gerlach J, Casey DE (1988) Tardive dyskinesia. Acta Psychiatr Scand 77:369–378
Itoh H (1981) Drug-induced tardive dyskinesia. In: Essman W, Valzelli L (eds) Current developments in psychopharmacology, vol 6. Spectrum, New York, pp 93–126
Itoh H (1985) Pharmacotherapy of schizophrenia: its present status and controversial points. Seishin Igaku 27:521–530
Itoh H, Yagi G, Ogita K, Ohtuka N, Sakurai S, Suzuki T, Tashiro I, Kaizawa S, Kamijima K, Koga Y, Miura S (1977) The assessment of tardive dyskinesia by the AIMS (Japanese version). Ann Rep Pharmacopsychiatr Res Found 9:218–225
Kane JM, Smith JM (1982) Tardive dyskinesia. Prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39:473–481
Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B (1982) A prospective study of tardive dyskinesia development: preliminary results. J Clin Psychopharmacol 2:345–349
Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B (1984) Incidence of tardive dyskinesia: five-year data from a prospective study. Psychopharmacol Bull 20:387–389
Kane JM, Woerner M, Borenstein M, Wegner J, Lieberman J (1986) Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 22:254–258
Tepper SJ, Haas JF (1979) Prevalence of tardive dyskinesia. J Clin Psychiatry 40:508–516
Yagi G (1980) Tardive dyskinesia in 1970's. Seishin Igaku 22:191–211
Yagi G, Itoh H (1985) A 10-year follow-up study of tardive dyskinesia: with special reference to the influence of neuroleptic administration on the long-term prognosis. Keio J Med 34: 211–219
Yagi G, Itoh H (1987) Follow-up study of 11 patients with potentially reversible tardive dyskinesia Am J Psychiatry 144:1496–1498
Yagi G, Ogita K Ohtsuka N, Itoh H, Miura S (1976) Persistent dyskinesia after long-term treatment with neuroleptics in Japan: its present status and clinical problems. Keio J Med 25:27–35
Yagi G, Takamiya M, Kanba S, Kamijima K (1989) Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study. Keio J Med 38:70–72
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inada, T., Ohnishi, K., Kamisada, M. et al. A prospective study of tardive dyskinesia in Japan. Eur Arch Psychiatry Clin Nuerosci 240, 250–254 (1991). https://doi.org/10.1007/BF02189535
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02189535